|
Product Description:
Fem-Dophilus contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus, GR-1 and Limosilactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilis from stomach acid and enhances probiotic bacterial survival to the lower intestine.
Warnings:
Keep out of the reach of children. Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition, if adverse reactions occur, discontinue use.
Additional Info:
Keep refrigerated. Suitable for vegetarians/ vegans. Made in Denmark.
Packaging:
Paperboard
Other Ingredients:
Maltodextrin (Non-GMO source), Vegetarian Capsule (Hyroxypropylmethylcellulose, Titanium Dioxide) Cellulose and Magnesium Stearate (Vegetable Source)
Does Not Contain:
Free of Major Allergens.
Suggested Use:
For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed, or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Supplement Facts
Serving Size: 1 Capsule
Servings Per Container: 30
Amount Per Serving
| Proprietary Probiotic Blend |
134 mg (5 Billion CFUs) |
| Lactocaseibacillus Rhamnosus GR-1 |
| Limosilactobacillus Reuteri RC-14 |
|
|
Related Products
|
Enlarge Image
